Robert Ettlinger (he/him) is a Rheumatologist in Tacoma, WA with over 18 years of experience. What is your opinion of Robert Ettlinger? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Robert Ettlinger has received over $751,011 which includes payments from the following companies:
$193,822.90 from Amgen Inc.
$152,242.11 from Pfizer Inc.
$83,041.94 from Celgene Corporation
$81,172.00 from LILLY USA, LLC
$76,606.16 from Regeneron Healthcare Solutions, Inc.
$64,592.23 from Novartis Pharmaceuticals Corporation
$42,123.66 from Takeda Pharmaceuticals America, Inc.
$32,825.75 from E.R. Squibb & Sons, L.L.C.
$15,411.37 from GENZYME CORPORATION
$7,886.67 from UCB, Inc.
$540.82 from GlaxoSmithKline, LLC.
$200.00 from COMSORT, Inc
$185.15 from AbbVie, Inc.
$103.34 from Genentech USA, Inc.
$79.20 from AstraZeneca Pharmaceuticals LP
$73.31 from Radius Health, Inc.
$64.00 from Janssen Scientific Affairs, LLC
$23.74 from Regeneron Pharmaceuticals, Inc.
$17.07 from Mission Pharmacal Company
Payments received by Robert Ettlinger were from the following categories:
$488,924.25 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!